Replies to post #224131 on Bioelectronics Corp (BIEL)

[Simpsonly]

Agreed!
I just would have gone at it a lot differently and with total transparency, fairness to ALL those supporting my dream and less self-serving. But, that's just me.

My underlying, and sometimes somewhat open, point to the incessant, and, believe me, tedious and boring, references to fixing the BoD and share structure is simple. Pssst, I have far better things to do.

It is a rare golden opportunity for someone now to redeem herself, from that which she has inherited.....and had no control over.

I knew the score, far better than you and many think. Some redeeming qualities, some over the years that made me shudder. A constant situation, for over a decade, where I could have said, "I told told you so, but didn't, because listening was not a strong suit. You with me?

So, I said it differently - "I warned you!", to which there was only one response, a somewhat meek, "I know....". Called no wiggle room. Good guy in many ways, but life and health and obvious stressors beat him....

Back to it, There is an amazing tactical opportunity for someone to make many tens of millions MORE, AND to take the high road and come out of a crappy toilet situation she inherited, a hero AND smelling like a rose. How often does that happen? Taking it is a matter of seeing the clear opportunity AND character. We shall see....soon.

[4toSchool]

At a guaranteed 216% ROI on a 2-year note, the Whelans are the toxic lenders.

The 216% ROI directly reduces the current shareholder's equity positions.

For example, a current note is due in May, in the approximate amount of $157,000. That note can be converted to about 2.5% of BIEL.

In essence, this noteholder is buying BIEL at a valuation of $6.3 when the market cap is $14 million. So, this noteholder is getting part of the existing shareholder's equity. Investors are getting screwed by "friendly investors".

At this rate, non-insider investors will have the value of their investment diluted to a "nominal" value.